Less Vertebral Bone Mass after Treatment with Macitentan in Mice: A Pilot Study.
Purpose. Blood vessels and skeleton interact together. Endothelin-1 is a potent vasoconstrictor and also has an effect on bone metabolism. The dual antagonist to both endothelin-1 type A and B receptors, Macitentan, has been approved for clinical management of pulmonary arterial hypertension while l...
| Publicado en: | BioMed Research International pp. 1 - 7 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | diagnostic images pictorial research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
2/19/2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |